16 May 2018

Recently, Rosa Geurtzen was awarded by ZonMw as appreciation for her role in a project that contributes to making effective choices in healthcare. She received the scholarship for the PreCo study, in which prenatal counseling in extreme preterm birth is optimized.

The prize of 2500 euros can be spent on an (international) course or conference visit in the field of efficiency. Rosa is PhD student on the PreCo study and resident in pediatrics. Shared decision-making for impending preterm delivery at the threshold of viability Prenatal counselling is the dialogue between parent(s) and physicians that takes place before the birth of a child in the case of impending preterm delivery at the threshold of viability. According to the Dutch guideline, parents need to be involved in decision-making at a gestational age of 24 weeks. The impact of extreme preterm birth is enormous, because a significant proportion of children will not survive and the children who survive may have serious health problems. Parents must be able to participate in the decision-making process to decide for active care (intensive care) or palliative comfort care at this early gestation. The nationwide PreCo project (Prenatal Counseling in extreme prematurity) of the Radboudumc Amalia childrens hospital has developed a framework with recommendations for the organization, decision-making, content and style of prenatal counseling. This framework was developed with involved parents, neonatologists and obstetricians. One of the important recommendations of the framework is shared decision-making (SDM) and the framework also provides practical advices on how to perform SDM. At present, a decision-aid is being developed to further support informed decision-making. More information can be found here .
Rosa is member of the theme Healthcare improvement science and supervised by Jos Draaisma, Arno van Heijst, Rosella Hermens, Marije Hogeveen.


Related news items

More than five million euros for research to improve palliative care Jeroen Hasselaar will lead research project with Horizon grant

15 June 2022

Jeroen Hasselaar will lead a large international research project. With a 5.3 million euro grant from the EU's Horizon program, he and his team want to improve palliative care for cancer patients, together with partners from nine European countries.

read more

Tailored drug dosage for pregnant women

14 March 2022

Three quarters of women in the Netherlands use some form of medication during pregnancy, but little is known about the appropriate dosages. Research by the Radboudumc, MUMC+ and Lareb Mothers of Tomorrow should change this.

read more

Most COVID-19 ICU survivors experience symptoms one year after ICU admission Publication in JAMA

25 January 2022

75% of the COVID-19 survivors who were treated in the Intensive Care Unit (ICU) experience physical, mental and/or cognitive problems one-year post ICU. This shows the large-scale MONITOR-IC study led by Radboudumc.

read more

1.4 million euro to reduce hospital admissions due to medication

7 January 2022

A team of sixteen Dutch hospitals received a grant of 1.4 million euros from ZonMw. They will investigate whether they can reduce medication related hospital readmissions.

read more

Participating in cancer research among people with intellectual disabilities

30 November 2021

Thanks to the support of the Maarten van der Weijden Foundation research was carried out into the participation of people with intellectual disabilities in (population) screening for cancer.

read more

Telemonitoring in chronic heart failure not unqualifiedly positive often additional demand for care without decreasing number of admissions

19 October 2021

To contain rising healthcare costs, digitization of healthcare is often seen as a solution. Researchers at the Radboudumc examined the use of telemonitoring in chronic heart failure. Does this reduce hospital admissions and visits to the emergency room?

read more